For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. |
European Insurance Dynamics 2026ThesisEuropean insurers enter 2026 from a position of structural strength (Solvency II ratios 190%-260%), but sector valuations are stretched — forward P/E 12.9x (+2.44 SD above 10-year mean) and P/BV 2.25x (+1.96 SD). Reporting reveals a performance divergence between capital markets-sensitive compounders (ALV, AXA, SLHN) and pure-play reinsurers (MUV2, SREN, HNR1, SCR) facing a moderating pricing cycle after January 2026's first risk-adjusted pricing decline since 2017. Top Picks (CFRA)
Exposed companies (2) Allianz SEALV GR AXA SACS FP |
European Insurance Dynamics 2026
Thesis
European insurers enter 2026 from a position of structural strength (Solvency II ratios 190%-260%), but sector valuations are stretched — forward P/E 12.9x (+2.44 SD above 10-year mean) and P/BV 2.25x (+1.96 SD). Reporting reveals a performance divergence between capital markets-sensitive compounders (ALV, AXA, SLHN) and pure-play reinsurers (MUV2, SREN, HNR1, SCR) facing a moderating pricing cycle after January 2026's first risk-adjusted pricing decline since 2017.
Top Picks (CFRA)
Prudential Plc (PRU LN) — Top pick. Compelling Asia/Africa pure-growth narrative. Double-digit NBP growth (+10% Y/Y in Q1, $686M), $1.2B buyback underway, 16.9% CAGRE (highest in coverage). Trades at only 1.8x P/BV vs. sector 2.8x. Over 80% of revenues in Asia/Africa — exposed to USD strength and Greater China regulatory risk, but demographic tailwind is multi-decade.
Allianz SE (ALV GR) — Record operating profit, core ROE 24.2%. EUR2T+ third-party AUM via PIMCO/AllianzGI generated €45B net inflows. Fee-based earnings provide underwriting cycle insulation. Top-end 6%-8% EPS growth guided for 2026.
AXA SA (CS FP) — Re-rating driven by P&C re-underwriting and AXA XL hard market tailwinds. Solvency II ratio >220%. Reinvestment of non-core Asset Management proceeds (sale of AXA IM to BNP Paribas) supports accelerated share repurchases (€1.6B+ per annum).